License Deal Ends IP Spat Between Caliper, BD

Law360, New York (January 11, 2010, 5:38 PM EST) -- Medical technology company Becton Dickinson and Co. has acquired a license to the microfluidics patent portfolio of Caliper Life Sciences Inc., ending intellectual property litigation between the firms over technologies concerning real-time amplification of small pieces of DNA for research purposes.

Caliper, whose microfluidic, or “lab-on-a-chip,” technologies allow researchers to control minute amounts of fluids contained in glass or plastic chips, announced the licensing agreement Monday.

Becton-owned HandyLab Inc., which had initiated the declaratory action against Caliper in July, withdrew its case in the U.S. District...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.